×

Download this application note

First Name
Last Name
Company Name
Country
State
Province
State
Region
State
Canton
Yes, add me to the NanoTemper email list!
By checking this box, you provide us consent to email you educational content, and information on our products, services and events. You may unsubscribe at any time.
Agree to Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.
Thank you!
Error - something went wrong!
   

Analysis of formulation-dependent colloidal and conformational stability of monoclonal antibodies

The growing number of biological drugs such as monoclonal antibodies (mAbs), as well as the wealth of heterogeneity between mAb variants requires a thorough development process to maximize mAbs compliance with regulation. Therefore, biophysical analytical methods are required already at early stages of the development process to guide and streamline further antibody processing and to predict antibody developability. In this case study, we demonstrate how the Prometheus NT.48 can be used to predict long-term mAb stability in a formulation screen by simultaneous quantification of both, conformational and colloidal stability of biologicals in thermal gradients.

Previous
Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development
Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development

Next
Thermal Stability Buffer Screening of Therapeutic Antibodies
Thermal Stability Buffer Screening of Therapeutic Antibodies

Have a question?

Contact Specialist